These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7679219)

  • 1. Locomotor activity in mice during chronic treatment with caffeine and withdrawal.
    Nikodijević O; Jacobson KA; Daly JW
    Pharmacol Biochem Behav; 1993 Jan; 44(1):199-216. PubMed ID: 7679219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice.
    Shi D; Nikodijević O; Jacobson KA; Daly JW
    Arch Int Pharmacodyn Ther; 1994; 328(3):261-87. PubMed ID: 7625882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding.
    Kaplan GB; Greenblatt DJ; Kent MA; Cotreau-Bibbo MM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1563-72. PubMed ID: 8371158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Combinations of Methylxanthines and Adenosine Analogs on Locomotor Activity in Control and Chronic Caffeine-Treated Mice.
    Nikodijević O; Jacobson KA; Daly JW
    Drug Dev Res; 1993 Oct; 30(2):104-110. PubMed ID: 38250653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral interaction of adenosine and methylxanthines on central purinergic systems.
    Coffin VL; Taylor JA; Phillis JW; Altman HJ; Barraco RA
    Neurosci Lett; 1984 Jun; 47(2):91-8. PubMed ID: 6205333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral characteristics of centrally administered adenosine analogs.
    Phillis JW; Barraco RA; DeLong RE; Washington DO
    Pharmacol Biochem Behav; 1986 Feb; 24(2):263-70. PubMed ID: 2419924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic effects of xanthines on levels of central receptors in mice.
    Shi D; Daly JW
    Cell Mol Neurobiol; 1999 Dec; 19(6):719-32. PubMed ID: 10456233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine stimulates locomotor activity in the mammalian spinal cord via adenosine A1 receptor-dopamine D1 receptor interaction and PKA-dependent mechanisms.
    Acevedo J; Santana-Almansa A; Matos-Vergara N; Marrero-Cordero LR; Cabezas-Bou E; Díaz-Ríos M
    Neuropharmacology; 2016 Feb; 101():490-505. PubMed ID: 26493631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity.
    Finn IB; Holtzman SG
    Psychopharmacology (Berl); 1987; 93(4):428-34. PubMed ID: 3124175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors.
    El Yacoubi M; Ledent C; Ménard JF; Parmentier M; Costentin J; Vaugeois JM
    Br J Pharmacol; 2000 Apr; 129(7):1465-73. PubMed ID: 10742303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors.
    Choi OH; Shamim MT; Padgett WL; Daly JW
    Life Sci; 1988; 43(5):387-98. PubMed ID: 2456442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
    Bilbao A; Cippitelli A; Martín AB; Granado N; Ortiz O; Bezard E; Chen JF; Navarro M; Rodríguez de Fonseca F; Moratalla R
    Psychopharmacology (Berl); 2006 Apr; 185(2):160-8. PubMed ID: 16470403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.
    Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Casas M; Ungerstedt U; Andén NE
    Eur J Pharmacol; 1991 Jan; 192(1):31-7. PubMed ID: 1828237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors.
    Halldner L; Adén U; Dahlberg V; Johansson B; Ledent C; Fredholm BB
    Neuropharmacology; 2004 Jun; 46(7):1008-17. PubMed ID: 15081797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice.
    Kuzmin A; Johansson B; Gimenez L; Ogren SO; Fredholm BB
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):129-36. PubMed ID: 16054807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
    Shamim MT; Ukena D; Padgett WL; Daly JW
    J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice.
    Hsu CW; Wang CS; Chiu TH
    J Biomed Sci; 2010 Jan; 17(1):4. PubMed ID: 20074377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
    Karcz-Kubicha M; Antoniou K; Terasmaa A; Quarta D; Solinas M; Justinova Z; Pezzola A; Reggio R; Müller CE; Fuxe K; Goldberg SR; Popoli P; Ferré S
    Neuropsychopharmacology; 2003 Jul; 28(7):1281-91. PubMed ID: 12700682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine.
    Barraco RA; Coffin VL; Altman HJ; Phillis JW
    Brain Res; 1983 Aug; 272(2):392-5. PubMed ID: 6616215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions in the behavioral effects of methylxanthines and adenosine derivatives.
    Katims JJ; Annau Z; Snyder SH
    J Pharmacol Exp Ther; 1983 Oct; 227(1):167-73. PubMed ID: 6194284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.